Funder
National Cancer Institute
Hacettepe Üniversitesi
Reference30 articles.
1. Systemic sclerosis;Denton;Lancet Lond Engl,2017
2. Systemic sclerosis-associated interstitial lung disease;Perelas;Lancet Respir Med,2020
3. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial;Tashkin;Lancet Respir Med,2016
4. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial;Khanna;Lancet Respir Med,2020
5. Nintedanib for systemic sclerosis-associated interstitial lung disease;Distler;N Engl J Med,2019